Testosterone Enanthate

evidence score
anabolic
Prescription Only
Test ET-enanthateDelatestryl+1 more

Testosterone Enanthate is the most widely used long-acting esterified testosterone. FDA-approved for male hypogonadism and delayed puberty. The enanthate ester provides a 7-10 day half-life, allowing once or twice-weekly injections for stable blood levels. Testosterone is the reference anabolic androgenic steroid from which all others are compared. It provides dose-dependent increases in lean mass, strength, bone density, red blood cell production, and sexual function. At TRT doses (100-200mg/week), side effects are minimal with proper monitoring. At supraphysiological doses used in bodybuilding contexts, significant cardiovascular and hormonal risks emerge. Requires AI (aromatase inhibitor) and PCT management in non-TRT protocols.

Evidence

No score yet

Safety

Unknown safety profile

Clinical Status

No formal phase listed

Research Sync

Not synced yet

Dosing

Typical
200 mg
100 mgRange500 mg
Frequencyweekly or twice weekly

Set height & weight in Settings to see your dose.

Pharmacology

Half-life~7-10 days (ester cleavage rate)
OnsetHormonal changes within 1-2 weeks; anabolic effects peak 4-8 weeks
DurationLevels stabilize with consistent weekly dosing; effects persist during protocol
Routes
intramuscular_injection
subcutaneous_injection

Evidence Score

0 studies indexed
Scoring Factors
Volume(40%)
Quality(30%)
Sample Size(10%)
Consistency(10%)
Replication(5%)
Recency(5%)
Evidence Levels
AScore ≥75 with at least 1 meta-analysis and 3+ RCTs
BScore ≥50 with at least 1 RCT or meta-analysis
CScore ≥25 — observational or animal evidence only
DScore <25 — very limited or preclinical data

Plain-English Snapshot

Testosterone Enanthate is currently categorized as a anabolic compound.

Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.

Safety scoring is incomplete. Start conservatively and monitor carefully.

Core mechanism

Binds androgen receptor; drives muscle protein synthesis via mTOR/PI3K/Akt; inhibits glucocorticoid receptors; erythropoietin stimulation; aromatizes to estradiol

Practical Context

Strongest current signals

No indexed study summaries yet.

Elevated caution signals

1 severe/high side effect flag

Compound Profile